Market research reports on: DNA, RNA, proteomics, genomics, genetics, cancer, cell, protein, sequencing, biomarkers, peptides, in vitro diagnostics, molecular and others.
Let's ConnectCell Harvesting Market
The global market for cell harvesting should grow from $885 million in 2018 to reach $1.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.3% for the period of 2018-2023.
Cell Viability Assays and Consumables: Global Markets
The global market for cell viability assays should grow from $2.7 billion in 2018 to reach $4.1 billion by 2023 at a compound annual growth rate (CAGR) of 8.3% for the period of 2018-2023.
Validation, Calibration and Standardization in the Life Sciences ...
The global market for validation, calibration and standardization in the global life sciences should grow from $1.5 billion in 2018 to reach $2.1 billion by 2023 at a compound annual growth rate (CAGR) of 6.7% for the period of 2018-2023.
Current Bioprinting Prospects and Future Innovations
The global bioprinting market should reach $1.4 billion by 2024 from $306.2 million in 2019 at a compound annual growth rate (CAGR) of 35.4% for the period 2019 to 2024.
Cancer Profiling and Pathways: Technologies and Global Markets
The global market for cancer profiling technologies should grow from $45.2 billion in 2018 to $90.6 billion by 2023 with a compound annual growth rate (CAGR) of 14.9% for the period of 2018-2023.
Emerging Jobs in Life Sciences and What You Should Be Training fo...
To develop and more importantly to improve current technologies, the market needs a pipeline of talent: well-educated and skilled scientists. Today, a new graduate or scientist with an immunology background will have a strong advantage in the market.The market for NGS applications reached $2.7 billion in 2016 and is expected to expand to $10.5 billion by 2022.The expanding biotech market offers a variety of careers. In some cases, we need to be creative and see behind the obvious scientific path.
Synthetic (Cultured) Meat: Technologies and Global Markets
The global synthetic (cultured) meat market should reach $19.8 million by 2027 from $16.3 million in 2022 at a compound annual growth rate (CAGR) of 4.0% for the period 2022-2027.
Protein Expression: Global Markets
The global market for protein expression should grow from $1.8 billion in 2017 to $3.1 billion by 2022 at a compound annual growth rate (CAGR) of 11.3% from 2017 through 2022.
Cancer Cell Analysis, Instruments, Consumables and Reagents
The global market for cancer cell analysis should reach $10.8 billion by 2023 from $7.4 billion in 2018 at a compound annual growth rate (CAGR) of 7.8% for the period of 2018-2023.
Cell Separation and Characterization in Solid Tumors: Global Mark...
The global market for cell separation and characterization in solid tumors should grow from $1.8 billion in 2018 to reach $3.3 billion by 2023 at a compound annual growth rate (CAGR) of 12.5% for the period of 2018-2023.
Biomarker Deals: Terms, Value and Trends, 2008-2018
Over the last decade, biomarker research has become one of the essential aspects not only of the in vitro diagnostics industry but an important component of the drug discovery and development process. Moreover, with the growing trend in personalized medicine and companion diagnostics, the use of biomarkers is becoming obligatory in management of certain diseases, such as cancer drug regimen.
Protein Analysis: Subfocus on Oncoproteomics
The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.
Genetic Modification Therapies Clinical Applications: Gene Thera...
The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.
Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...
The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.
Switching to CRISPR-Cas Systems from Uncultivated Microbes
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.
Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...
Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.
Immunohistochemistry (IHC): Global Markets to 2022
The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.
The Chinese Market for DNA Sequencing
The Chinese market for DNA sequencing totaled $1.2 billion in 2017. The market should total $2.9 billion by 2022, growing at a compound annual growth rate (CAGR) of 19.0% during 2017-2022.
Cell Therapy Processing: Global Markets and Technologies
The global market for cell therapy reached $1.3 billion in 2017 and should reach $5.0 billion in 2022 at a compound annual growth rate (CAGR) of 30.9% for the period of 2017-2022.
Mobile Apps for DNA Sequencing: Global Markets
The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.
Global Markets for Enzyme Inhibitors
The global market for enzyme inhibitors should reach $179.9 billion by 2022 from $168 billion in 2017 at a compound annual growth rate (CAGR) of 1.4%, from 2017 to 2022.
Botanical and Plant-derived Drugs: Global Markets
The global market for botanical and plant-derived drugs will grow from $29.4 billion in 2017 to around $39.6 billion by 2022 with a compound annual growth rate (CAGR) of 6.1% for the period of 2017-2022.
Separation Systems for Commercial Biotechnology
The global market for bioseparation reached $18.4 billion in 2015. This market is expected to increase from $19.0 billion in 2016 to nearly $24.0 billion in 2021 at a compound annual growth rate (CAGR) of 4.7% for 2016-2021.
Global Markets for Protein Labeling
The global protein-labeling market reached $2.2 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 14.1% from 2016 to 2021.
Cell Expansion Technologies and Global Markets
The global cell expansion market generated revenue of roughly $8.5 billion in 2014, and is expected to reach revenues of $9.7 billion in 2015 and $22.0 billion by 2020, with a compound annual growth rate (CAGR) of 17.8% from 2015 to 2020.
The Chinese Market for DNA Sequencing
This report provides an overview of the Chinese Market for DNA Sequencing and analyzes market trends.
Molecular Diagnostics: Technologies and Global Markets
The report provides an overview of the global molecular diagnostics market and analyzes market trends. It includes global revenue ($ millions) for the base year 2024 and estimated data for 2025 and CAGR forecasts through 2030.
Biological Therapies for Cancer: Technologies and Global Markets
This report provides an overview of the global biological therapies for the cancer market and analyzes market trends. It includes global revenue ($ million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.
mRNA: Therapeutics and Global Markets
This report provides an overview of the global mRNA therapeutics market and analyzes market trends.
Biomarker Deals: Terms Value and Trends 2019-2025
This report examines the business terms and conditions prevalent in biomarker market deals. It highlights key trends in biomarker partnerships, profiles major participating companies, and explores future opportunities for out-licensing, collaborations, and acquisitions.
Fusion Proteins: Global Market
This report provides an overview of the global fusion proteins market and analyzes market trends. It includes global revenue ($ Million) for the base year 2024, estimated data for 2025, and forecast data through 2030.
Cell Therapy Processing: Global Markets and Technologies
This report provides an overview of the global market for Cell Therapy Processing. It includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.
Separation Systems for Commercial Biotechnology
The report provides an overview of the global bioseparation systems market and analyzes market trends. The report includes global revenue ($ million) for base year data 2024, estimated data for 2025, and forecast data for 2026 to 2030.
